Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ · Healthcare
Biomarin Pharmaceutical Inc. Shareholder Equity 2008–2025
Biomarin Pharmaceutical Inc. annual shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Biomarin Pharmaceutical Inc. shareholder equity as of December 31, 2025: 6.09B, a 7.58% increase year-over-year.
- Biomarin Pharmaceutical Inc. shareholder equity for 2025 were 6.09B, a 7.58% increase from 2024.
- Biomarin Pharmaceutical Inc. shareholder equity for 2024 were 5.66B, a 14.27% increase from 2023.
- Biomarin Pharmaceutical Inc. shareholder equity for 2023 were 4.95B, a 7.57% increase from 2022.
- Biomarin Pharmaceutical Inc. shareholder equity for 2022 were 4.60B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Biomarin Pharmaceutical Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $6,087 |
| 2024 | $5,658 |
| 2023 | $4,952 |
| 2022 | $4,603 |
| 2021 | $4,266 |
| 2020 | $4,101 |
| 2019 | $3,122 |
| 2018 | $2,968 |
| 2017 | $2,809 |
| 2016 | $2,766 |
| 2015 | $2,401 |
| 2014 | $1,528 |
| 2013 | $1,341 |
| 2012 | $1,016 |
| 2011 | $773 |
Biomarin Pharmaceutical Inc. Shareholder Equity — FAQ
Biomarin Pharmaceutical Inc. (BMRN) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMRN's shareholder equity history?
The chart and table above show Biomarin Pharmaceutical Inc.'s shareholder equity by year and by quarter, including the growth rate.